Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CRYPTOCOCCUS NEOFORMANS - ANVISA Registration 80254180243

Access comprehensive regulatory information for CRYPTOCOCCUS NEOFORMANS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180243 and manufactured by manufacturer not specified. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Jan 30, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including BIOSYNEX S.A., ALAMAR TECNO CIENTรFICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80254180243
2 Related Devices
Registration Details
ANVISA Registration Number: 80254180243
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

CRYPTOCOCCUS ANTIGEN LATEX TEST
Risk Class III

Registration Details

80254180243

25351151378201702

04930429000139

Company Information

Dates and Status

Apr 24, 2017

30/01/2026

09/18/2025 19:00:01

CRYPTOCOCCUS ANTIGEN LATEX TEST
Risk Class III

Registration Details

80254180243

25351151378201702

04930429000139

Company Information

REMEL INC
United States of America
PT: ESTADOS UNIDOS DA AMร‰RICA

Dates and Status

Apr 24, 2017

30/01/2026

09/18/2025 19:00:01